nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—CYP1A1—Propranolol—migraine	0.156	0.236	CbGbCtD
Bezafibrate—SLCO1B1—Verapamil—migraine	0.146	0.221	CbGbCtD
Bezafibrate—CYP2C8—Amitriptyline—migraine	0.078	0.118	CbGbCtD
Bezafibrate—CYP2C8—Valproic Acid—migraine	0.0711	0.107	CbGbCtD
Bezafibrate—CYP2C8—Verapamil—migraine	0.0619	0.0935	CbGbCtD
Bezafibrate—CYP3A4—Propranolol—migraine	0.0366	0.0553	CbGbCtD
Bezafibrate—CYP3A4—Amitriptyline—migraine	0.0316	0.0478	CbGbCtD
Bezafibrate—CYP3A4—Valproic Acid—migraine	0.0288	0.0436	CbGbCtD
Bezafibrate—CYP3A4—Topiramate—migraine	0.026	0.0393	CbGbCtD
Bezafibrate—CYP3A4—Verapamil—migraine	0.0251	0.0379	CbGbCtD
Bezafibrate—Epigastric distress—Amitriptyline—migraine	0.00957	0.0423	CcSEcCtD
Bezafibrate—PPARG—Differentiation of white and brown adipocyte   —PRDM16—migraine	0.00821	0.122	CbGpPWpGaD
Bezafibrate—Epigastric distress—Propranolol—migraine	0.0078	0.0344	CcSEcCtD
Bezafibrate—PPARA—blood vessel—migraine	0.00468	0.105	CbGeAlD
Bezafibrate—Cholestasis—Verapamil—migraine	0.00366	0.0162	CcSEcCtD
Bezafibrate—HMGCR—Statin Pathway—LRP1—migraine	0.00362	0.0537	CbGpPWpGaD
Bezafibrate—PPARA—neck—migraine	0.00335	0.0749	CbGeAlD
Bezafibrate—PPARA—Transcriptional activation of mitochondrial biogenesis—MEF2D—migraine	0.0032	0.0474	CbGpPWpGaD
Bezafibrate—Vascular purpura—Amitriptyline—migraine	0.00301	0.0133	CcSEcCtD
Bezafibrate—Purpura—Amitriptyline—migraine	0.0028	0.0123	CcSEcCtD
Bezafibrate—PPARA—Mitochondrial biogenesis—MEF2D—migraine	0.00276	0.0409	CbGpPWpGaD
Bezafibrate—PPARA—Circadian Clock—MEF2D—migraine	0.00272	0.0403	CbGpPWpGaD
Bezafibrate—Cholelithiasis—Gabapentin—migraine	0.00263	0.0116	CcSEcCtD
Bezafibrate—PPARG—blood vessel—migraine	0.00257	0.0576	CbGeAlD
Bezafibrate—PPARD—Nuclear Receptors—PGR—migraine	0.00246	0.0364	CbGpPWpGaD
Bezafibrate—Vascular purpura—Propranolol—migraine	0.00245	0.0108	CcSEcCtD
Bezafibrate—Blood creatine phosphokinase increased—Gabapentin—migraine	0.00237	0.0105	CcSEcCtD
Bezafibrate—PPARA—Estrogen Receptor Pathway—ESR1—migraine	0.00236	0.035	CbGpPWpGaD
Bezafibrate—Purpura—Propranolol—migraine	0.00228	0.0101	CcSEcCtD
Bezafibrate—Vascular purpura—Verapamil—migraine	0.00226	0.00996	CcSEcCtD
Bezafibrate—HMGCR—neck—migraine	0.00223	0.0499	CbGeAlD
Bezafibrate—Pancytopenia—Amitriptyline—migraine	0.00221	0.00977	CcSEcCtD
Bezafibrate—Erectile dysfunction—Amitriptyline—migraine	0.00214	0.00947	CcSEcCtD
Bezafibrate—Purpura—Verapamil—migraine	0.00209	0.00925	CcSEcCtD
Bezafibrate—PPARA—cardiovascular system—migraine	0.00209	0.0467	CbGeAlD
Bezafibrate—Acute coronary syndrome—Amitriptyline—migraine	0.00205	0.00904	CcSEcCtD
Bezafibrate—Myocardial infarction—Amitriptyline—migraine	0.00204	0.00899	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Propranolol—migraine	0.00198	0.00872	CcSEcCtD
Bezafibrate—PPARD—Nuclear Receptor transcription pathway—PGR—migraine	0.00194	0.0288	CbGpPWpGaD
Bezafibrate—HMGCR—trigeminal ganglion—migraine	0.00192	0.0431	CbGeAlD
Bezafibrate—PPARA—Nuclear Receptors—PGR—migraine	0.00187	0.0278	CbGpPWpGaD
Bezafibrate—Rhabdomyolysis—Gabapentin—migraine	0.00185	0.00816	CcSEcCtD
Bezafibrate—PPARG—neck—migraine	0.00184	0.0412	CbGeAlD
Bezafibrate—Bronchitis—Propranolol—migraine	0.00182	0.00805	CcSEcCtD
Bezafibrate—Cramp muscle—Verapamil—migraine	0.00182	0.00803	CcSEcCtD
Bezafibrate—PPARD—Adipogenesis—MEF2D—migraine	0.0018	0.0266	CbGpPWpGaD
Bezafibrate—Muscular weakness—Verapamil—migraine	0.00178	0.00786	CcSEcCtD
Bezafibrate—Erectile dysfunction—Propranolol—migraine	0.00175	0.00771	CcSEcCtD
Bezafibrate—Influenza—Verapamil—migraine	0.00174	0.0077	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Propranolol—migraine	0.00168	0.0074	CcSEcCtD
Bezafibrate—PPARD—head—migraine	0.00166	0.0371	CbGeAlD
Bezafibrate—Alopecia—Amitriptyline—migraine	0.00165	0.00727	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Gabapentin—migraine	0.00163	0.00722	CcSEcCtD
Bezafibrate—Photosensitivity—Valproic Acid—migraine	0.00163	0.0072	CcSEcCtD
Bezafibrate—Erectile dysfunction—Verapamil—migraine	0.00161	0.00709	CcSEcCtD
Bezafibrate—PPARD—nervous system—migraine	0.00157	0.0352	CbGeAlD
Bezafibrate—Stevens-Johnson syndrome—Verapamil—migraine	0.00154	0.00681	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Verapamil—migraine	0.00153	0.00677	CcSEcCtD
Bezafibrate—Myocardial infarction—Verapamil—migraine	0.00152	0.00673	CcSEcCtD
Bezafibrate—PPARD—central nervous system—migraine	0.00151	0.0339	CbGeAlD
Bezafibrate—Pharyngitis—Propranolol—migraine	0.00151	0.00665	CcSEcCtD
Bezafibrate—PPARA—Nuclear Receptor transcription pathway—PGR—migraine	0.00148	0.0219	CbGpPWpGaD
Bezafibrate—PPARD—cerebellum—migraine	0.00148	0.0331	CbGeAlD
Bezafibrate—Erythema multiforme—Propranolol—migraine	0.00144	0.00634	CcSEcCtD
Bezafibrate—PPARA—head—migraine	0.00141	0.0316	CbGeAlD
Bezafibrate—HMGCR—cardiovascular system—migraine	0.00139	0.0311	CbGeAlD
Bezafibrate—Pharyngitis—Verapamil—migraine	0.00139	0.00612	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Topiramate—migraine	0.00137	0.00607	CcSEcCtD
Bezafibrate—PPARA—Adipogenesis—MEF2D—migraine	0.00137	0.0203	CbGpPWpGaD
Bezafibrate—Blood alkaline phosphatase increased—Gabapentin—migraine	0.00136	0.00602	CcSEcCtD
Bezafibrate—PPARG—Nuclear Receptors—PGR—migraine	0.00134	0.0199	CbGpPWpGaD
Bezafibrate—Alopecia—Propranolol—migraine	0.00134	0.00592	CcSEcCtD
Bezafibrate—PPARA—nervous system—migraine	0.00134	0.03	CbGeAlD
Bezafibrate—Vascular purpura—Gabapentin—migraine	0.00133	0.00586	CcSEcCtD
Bezafibrate—Erythema—Propranolol—migraine	0.00132	0.00583	CcSEcCtD
Bezafibrate—Erythema multiforme—Verapamil—migraine	0.00132	0.00583	CcSEcCtD
Bezafibrate—Eczema—Gabapentin—migraine	0.00132	0.00583	CcSEcCtD
Bezafibrate—PPARD—Nuclear Receptors—ESR1—migraine	0.00131	0.0194	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Amitriptyline—migraine	0.0013	0.00573	CcSEcCtD
Bezafibrate—PPARA—central nervous system—migraine	0.00129	0.0289	CbGeAlD
Bezafibrate—Toxic epidermal necrolysis—Valproic Acid—migraine	0.00129	0.00569	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Valproic Acid—migraine	0.00129	0.00569	CcSEcCtD
Bezafibrate—Renal failure acute—Gabapentin—migraine	0.00128	0.00567	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Valproic Acid—migraine	0.00126	0.00557	CcSEcCtD
Bezafibrate—Muscular weakness—Valproic Acid—migraine	0.00126	0.00557	CcSEcCtD
Bezafibrate—PPARA—cerebellum—migraine	0.00126	0.0282	CbGeAlD
Bezafibrate—PPARA—Organelle biogenesis and maintenance—MEF2D—migraine	0.00125	0.0186	CbGpPWpGaD
Bezafibrate—Influenza—Valproic Acid—migraine	0.00124	0.00546	CcSEcCtD
Bezafibrate—Alopecia—Verapamil—migraine	0.00123	0.00545	CcSEcCtD
Bezafibrate—Purpura—Gabapentin—migraine	0.00123	0.00544	CcSEcCtD
Bezafibrate—PPARD—brain—migraine	0.0012	0.0269	CbGeAlD
Bezafibrate—Insomnia—Amitriptyline—migraine	0.0012	0.00529	CcSEcCtD
Bezafibrate—Bronchitis—Valproic Acid—migraine	0.00119	0.00525	CcSEcCtD
Bezafibrate—Liver function test abnormal—Timolol—migraine	0.00118	0.00519	CcSEcCtD
Bezafibrate—Pancytopenia—Valproic Acid—migraine	0.00117	0.00519	CcSEcCtD
Bezafibrate—Muscle spasms—Verapamil—migraine	0.00117	0.00516	CcSEcCtD
Bezafibrate—Migraine—Gabapentin—migraine	0.00117	0.00516	CcSEcCtD
Bezafibrate—Dyspepsia—Amitriptyline—migraine	0.00117	0.00515	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Topiramate—migraine	0.00115	0.00507	CcSEcCtD
Bezafibrate—PPARG—cardiovascular system—migraine	0.00115	0.0257	CbGeAlD
Bezafibrate—Constipation—Amitriptyline—migraine	0.00113	0.005	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Valproic Acid—migraine	0.00113	0.00499	CcSEcCtD
Bezafibrate—Vascular purpura—Topiramate—migraine	0.00112	0.00493	CcSEcCtD
Bezafibrate—Blood creatinine increased—Gabapentin—migraine	0.00111	0.00491	CcSEcCtD
Bezafibrate—Eczema—Topiramate—migraine	0.00111	0.0049	CcSEcCtD
Bezafibrate—Liver function test abnormal—Gabapentin—migraine	0.0011	0.00484	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Valproic Acid—migraine	0.00109	0.00483	CcSEcCtD
Bezafibrate—Infection—Propranolol—migraine	0.00107	0.00473	CcSEcCtD
Bezafibrate—PPARG—Nuclear Receptor transcription pathway—PGR—migraine	0.00106	0.0157	CbGpPWpGaD
Bezafibrate—Urticaria—Amitriptyline—migraine	0.00105	0.00465	CcSEcCtD
Bezafibrate—Gastritis—Gabapentin—migraine	0.00105	0.00464	CcSEcCtD
Bezafibrate—Muscular weakness—Gabapentin—migraine	0.00105	0.00462	CcSEcCtD
Bezafibrate—PPARD—Nuclear Receptor transcription pathway—ESR1—migraine	0.00104	0.0154	CbGpPWpGaD
Bezafibrate—Purpura—Topiramate—migraine	0.00104	0.00457	CcSEcCtD
Bezafibrate—Myalgia—Verapamil—migraine	0.00103	0.00457	CcSEcCtD
Bezafibrate—Influenza—Gabapentin—migraine	0.00103	0.00453	CcSEcCtD
Bezafibrate—PPARA—brain—migraine	0.00102	0.0229	CbGeAlD
Bezafibrate—PPARD—Presenilin action in Notch and Wnt signaling—FOS—migraine	0.00102	0.015	CbGpPWpGaD
Bezafibrate—Erectile dysfunction—Timolol—migraine	0.00101	0.00448	CcSEcCtD
Bezafibrate—PPARA—Nuclear Receptors—ESR1—migraine	0.001	0.0148	CbGpPWpGaD
Bezafibrate—Bronchitis—Gabapentin—migraine	0.000986	0.00435	CcSEcCtD
Bezafibrate—Infection—Verapamil—migraine	0.000985	0.00435	CcSEcCtD
Bezafibrate—Pharyngitis—Valproic Acid—migraine	0.000983	0.00434	CcSEcCtD
Bezafibrate—Migraine—Topiramate—migraine	0.000982	0.00434	CcSEcCtD
Bezafibrate—PPARG—Adipogenesis—MEF2D—migraine	0.00098	0.0145	CbGpPWpGaD
Bezafibrate—Urinary tract disorder—Valproic Acid—migraine	0.000978	0.00432	CcSEcCtD
Bezafibrate—Insomnia—Propranolol—migraine	0.000975	0.00431	CcSEcCtD
Bezafibrate—Urethral disorder—Valproic Acid—migraine	0.00097	0.00429	CcSEcCtD
Bezafibrate—Dyspepsia—Propranolol—migraine	0.000949	0.00419	CcSEcCtD
Bezafibrate—Erectile dysfunction—Gabapentin—migraine	0.000944	0.00417	CcSEcCtD
Bezafibrate—HMGCR—head—migraine	0.00094	0.0211	CbGeAlD
Bezafibrate—Pruritus—Amitriptyline—migraine	0.000937	0.00414	CcSEcCtD
Bezafibrate—Erythema multiforme—Valproic Acid—migraine	0.000936	0.00413	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Gabapentin—migraine	0.000936	0.00413	CcSEcCtD
Bezafibrate—Blood creatinine increased—Topiramate—migraine	0.000935	0.00413	CcSEcCtD
Bezafibrate—Pain—Propranolol—migraine	0.000922	0.00407	CcSEcCtD
Bezafibrate—Constipation—Propranolol—migraine	0.000922	0.00407	CcSEcCtD
Bezafibrate—Liver function test abnormal—Topiramate—migraine	0.000921	0.00407	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Gabapentin—migraine	0.000906	0.004	CcSEcCtD
Bezafibrate—Diarrhoea—Amitriptyline—migraine	0.000906	0.004	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Verapamil—migraine	0.000904	0.00399	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Gabapentin—migraine	0.000901	0.00398	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Topiramate—migraine	0.000899	0.00397	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Topiramate—migraine	0.000899	0.00397	CcSEcCtD
Bezafibrate—Insomnia—Verapamil—migraine	0.000897	0.00396	CcSEcCtD
Bezafibrate—Myocardial infarction—Gabapentin—migraine	0.000896	0.00396	CcSEcCtD
Bezafibrate—HMGCR—nervous system—migraine	0.000891	0.02	CbGeAlD
Bezafibrate—Gastritis—Topiramate—migraine	0.000883	0.0039	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Propranolol—migraine	0.000882	0.00389	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Topiramate—migraine	0.00088	0.00389	CcSEcCtD
Bezafibrate—Muscular weakness—Topiramate—migraine	0.00088	0.00389	CcSEcCtD
Bezafibrate—Dizziness—Amitriptyline—migraine	0.000876	0.00387	CcSEcCtD
Bezafibrate—Alopecia—Valproic Acid—migraine	0.000875	0.00386	CcSEcCtD
Bezafibrate—Dyspepsia—Verapamil—migraine	0.000873	0.00386	CcSEcCtD
Bezafibrate—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—migraine	0.000862	0.0128	CbGpPWpGaD
Bezafibrate—HMGCR—central nervous system—migraine	0.000858	0.0192	CbGeAlD
Bezafibrate—Urticaria—Propranolol—migraine	0.000857	0.00378	CcSEcCtD
Bezafibrate—Abdominal pain—Propranolol—migraine	0.000852	0.00376	CcSEcCtD
Bezafibrate—Flatulence—Valproic Acid—migraine	0.000849	0.00375	CcSEcCtD
Bezafibrate—Pain—Verapamil—migraine	0.000848	0.00375	CcSEcCtD
Bezafibrate—Constipation—Verapamil—migraine	0.000848	0.00375	CcSEcCtD
Bezafibrate—HMGCR—cerebellum—migraine	0.000839	0.0188	CbGeAlD
Bezafibrate—Rash—Amitriptyline—migraine	0.000835	0.00369	CcSEcCtD
Bezafibrate—CYP1A1—Estrogen Receptor Pathway—ESR1—migraine	0.000834	0.0124	CbGpPWpGaD
Bezafibrate—Dermatitis—Amitriptyline—migraine	0.000834	0.00368	CcSEcCtD
Bezafibrate—Headache—Amitriptyline—migraine	0.00083	0.00366	CcSEcCtD
Bezafibrate—Bronchitis—Topiramate—migraine	0.00083	0.00366	CcSEcCtD
Bezafibrate—Muscle spasms—Valproic Acid—migraine	0.000829	0.00366	CcSEcCtD
Bezafibrate—PPARD—NRF2 pathway—SLC6A4—migraine	0.000821	0.0122	CbGpPWpGaD
Bezafibrate—Pancytopenia—Topiramate—migraine	0.000819	0.00362	CcSEcCtD
Bezafibrate—Pharyngitis—Gabapentin—migraine	0.000815	0.0036	CcSEcCtD
Bezafibrate—Urinary tract disorder—Gabapentin—migraine	0.00081	0.00358	CcSEcCtD
Bezafibrate—Urethral disorder—Gabapentin—migraine	0.000804	0.00355	CcSEcCtD
Bezafibrate—Anaemia—Valproic Acid—migraine	0.000797	0.00352	CcSEcCtD
Bezafibrate—Hypersensitivity—Propranolol—migraine	0.000794	0.00351	CcSEcCtD
Bezafibrate—Erectile dysfunction—Topiramate—migraine	0.000794	0.00351	CcSEcCtD
Bezafibrate—PPARA—Nuclear Receptor transcription pathway—ESR1—migraine	0.00079	0.0117	CbGpPWpGaD
Bezafibrate—Urticaria—Verapamil—migraine	0.000788	0.00348	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Topiramate—migraine	0.000787	0.00348	CcSEcCtD
Bezafibrate—Nausea—Amitriptyline—migraine	0.000787	0.00347	CcSEcCtD
Bezafibrate—Alopecia—Timolol—migraine	0.000779	0.00344	CcSEcCtD
Bezafibrate—PPARG—head—migraine	0.000777	0.0174	CbGeAlD
Bezafibrate—Erythema multiforme—Gabapentin—migraine	0.000776	0.00343	CcSEcCtD
Bezafibrate—Erythema—Timolol—migraine	0.000767	0.00339	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Topiramate—migraine	0.000763	0.00337	CcSEcCtD
Bezafibrate—Diarrhoea—Propranolol—migraine	0.000738	0.00326	CcSEcCtD
Bezafibrate—PPARG—nervous system—migraine	0.000737	0.0165	CbGeAlD
Bezafibrate—Myalgia—Valproic Acid—migraine	0.000734	0.00324	CcSEcCtD
Bezafibrate—Hypersensitivity—Verapamil—migraine	0.000731	0.00323	CcSEcCtD
Bezafibrate—Alopecia—Gabapentin—migraine	0.000725	0.0032	CcSEcCtD
Bezafibrate—PPARG—Nuclear Receptors—ESR1—migraine	0.000717	0.0106	CbGpPWpGaD
Bezafibrate—Erythema—Gabapentin—migraine	0.000714	0.00315	CcSEcCtD
Bezafibrate—Dizziness—Propranolol—migraine	0.000713	0.00315	CcSEcCtD
Bezafibrate—PPARG—central nervous system—migraine	0.000709	0.0159	CbGeAlD
Bezafibrate—Flatulence—Gabapentin—migraine	0.000704	0.00311	CcSEcCtD
Bezafibrate—Pruritus—Verapamil—migraine	0.000702	0.0031	CcSEcCtD
Bezafibrate—Infection—Valproic Acid—migraine	0.000699	0.00309	CcSEcCtD
Bezafibrate—Thrombocytopenia—Valproic Acid—migraine	0.000689	0.00304	CcSEcCtD
Bezafibrate—Muscle spasms—Gabapentin—migraine	0.000687	0.00303	CcSEcCtD
Bezafibrate—Pharyngitis—Topiramate—migraine	0.000685	0.00303	CcSEcCtD
Bezafibrate—Urinary tract disorder—Topiramate—migraine	0.000682	0.00301	CcSEcCtD
Bezafibrate—HMGCR—brain—migraine	0.000681	0.0153	CbGeAlD
Bezafibrate—Rash—Propranolol—migraine	0.00068	0.003	CcSEcCtD
Bezafibrate—Dermatitis—Propranolol—migraine	0.000679	0.003	CcSEcCtD
Bezafibrate—Diarrhoea—Verapamil—migraine	0.000679	0.003	CcSEcCtD
Bezafibrate—PPARA—Transmembrane transport of small molecules—TRPM8—migraine	0.000677	0.01	CbGpPWpGaD
Bezafibrate—Urethral disorder—Topiramate—migraine	0.000677	0.00299	CcSEcCtD
Bezafibrate—Anaemia—Gabapentin—migraine	0.00066	0.00292	CcSEcCtD
Bezafibrate—PPARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—migraine	0.000657	0.00973	CbGpPWpGaD
Bezafibrate—Dizziness—Verapamil—migraine	0.000656	0.0029	CcSEcCtD
Bezafibrate—Myalgia—Timolol—migraine	0.000653	0.00288	CcSEcCtD
Bezafibrate—Erythema multiforme—Topiramate—migraine	0.000653	0.00288	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Valproic Acid—migraine	0.000641	0.00283	CcSEcCtD
Bezafibrate—Nausea—Propranolol—migraine	0.000641	0.00283	CcSEcCtD
Bezafibrate—Insomnia—Valproic Acid—migraine	0.000636	0.00281	CcSEcCtD
Bezafibrate—Rash—Verapamil—migraine	0.000625	0.00276	CcSEcCtD
Bezafibrate—Dermatitis—Verapamil—migraine	0.000625	0.00276	CcSEcCtD
Bezafibrate—Infection—Timolol—migraine	0.000622	0.00275	CcSEcCtD
Bezafibrate—Headache—Verapamil—migraine	0.000621	0.00274	CcSEcCtD
Bezafibrate—PPARD—NRF2 pathway—TGFBR2—migraine	0.00062	0.00918	CbGpPWpGaD
Bezafibrate—Dyspepsia—Valproic Acid—migraine	0.000619	0.00273	CcSEcCtD
Bezafibrate—Alopecia—Topiramate—migraine	0.00061	0.00269	CcSEcCtD
Bezafibrate—Myalgia—Gabapentin—migraine	0.000608	0.00269	CcSEcCtD
Bezafibrate—PPARA—Developmental Biology—SCN1A—migraine	0.000605	0.00896	CbGpPWpGaD
Bezafibrate—Constipation—Valproic Acid—migraine	0.000601	0.00266	CcSEcCtD
Bezafibrate—Pain—Valproic Acid—migraine	0.000601	0.00266	CcSEcCtD
Bezafibrate—Erythema—Topiramate—migraine	0.000601	0.00265	CcSEcCtD
Bezafibrate—Flatulence—Topiramate—migraine	0.000592	0.00262	CcSEcCtD
Bezafibrate—Nausea—Verapamil—migraine	0.000589	0.0026	CcSEcCtD
Bezafibrate—Infection—Gabapentin—migraine	0.000579	0.00256	CcSEcCtD
Bezafibrate—Muscle spasms—Topiramate—migraine	0.000578	0.00255	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Valproic Acid—migraine	0.000575	0.00254	CcSEcCtD
Bezafibrate—Thrombocytopenia—Gabapentin—migraine	0.000571	0.00252	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Timolol—migraine	0.00057	0.00252	CcSEcCtD
Bezafibrate—PPARG—Nuclear Receptor transcription pathway—ESR1—migraine	0.000566	0.00839	CbGpPWpGaD
Bezafibrate—Insomnia—Timolol—migraine	0.000566	0.0025	CcSEcCtD
Bezafibrate—PPARG—brain—migraine	0.000563	0.0126	CbGeAlD
Bezafibrate—Urticaria—Valproic Acid—migraine	0.000559	0.00247	CcSEcCtD
Bezafibrate—Abdominal pain—Valproic Acid—migraine	0.000556	0.00246	CcSEcCtD
Bezafibrate—Anaemia—Topiramate—migraine	0.000556	0.00245	CcSEcCtD
Bezafibrate—Dyspepsia—Timolol—migraine	0.000551	0.00243	CcSEcCtD
Bezafibrate—PPARG—Transcription factor regulation in adipogenesis—TNF—migraine	0.000538	0.00797	CbGpPWpGaD
Bezafibrate—Pain—Timolol—migraine	0.000535	0.00236	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Gabapentin—migraine	0.000531	0.00235	CcSEcCtD
Bezafibrate—Insomnia—Gabapentin—migraine	0.000527	0.00233	CcSEcCtD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—migraine	0.000519	0.00768	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Valproic Acid—migraine	0.000518	0.00229	CcSEcCtD
Bezafibrate—PPARA—Developmental Biology—SCN2A—migraine	0.000514	0.00762	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—ATP1A2—migraine	0.000513	0.00761	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—ATP1A3—migraine	0.000513	0.00761	CbGpPWpGaD
Bezafibrate—Dyspepsia—Gabapentin—migraine	0.000513	0.00227	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Timolol—migraine	0.000512	0.00226	CcSEcCtD
Bezafibrate—Myalgia—Topiramate—migraine	0.000512	0.00226	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000502	0.00744	CbGpPWpGaD
Bezafibrate—Constipation—Gabapentin—migraine	0.000499	0.0022	CcSEcCtD
Bezafibrate—Pain—Gabapentin—migraine	0.000499	0.0022	CcSEcCtD
Bezafibrate—Pruritus—Valproic Acid—migraine	0.000498	0.0022	CcSEcCtD
Bezafibrate—Urticaria—Timolol—migraine	0.000497	0.0022	CcSEcCtD
Bezafibrate—Abdominal pain—Timolol—migraine	0.000495	0.00219	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—NPS—migraine	0.000494	0.00732	CbGpPWpGaD
Bezafibrate—Infection—Topiramate—migraine	0.000487	0.00215	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—SLC6A4—migraine	0.000485	0.00718	CbGpPWpGaD
Bezafibrate—Diarrhoea—Valproic Acid—migraine	0.000481	0.00213	CcSEcCtD
Bezafibrate—Thrombocytopenia—Topiramate—migraine	0.00048	0.00212	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Gabapentin—migraine	0.000477	0.00211	CcSEcCtD
Bezafibrate—CYP1A1—head—migraine	0.000473	0.0106	CbGeAlD
Bezafibrate—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—migraine	0.00047	0.00697	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MEF2D—migraine	0.00047	0.00697	CbGpPWpGaD
Bezafibrate—Dizziness—Valproic Acid—migraine	0.000465	0.00205	CcSEcCtD
Bezafibrate—Urticaria—Gabapentin—migraine	0.000463	0.00205	CcSEcCtD
Bezafibrate—Hypersensitivity—Timolol—migraine	0.000461	0.00204	CcSEcCtD
Bezafibrate—Abdominal pain—Gabapentin—migraine	0.000461	0.00204	CcSEcCtD
Bezafibrate—CYP1A1—nervous system—migraine	0.000448	0.01	CbGeAlD
Bezafibrate—Musculoskeletal discomfort—Topiramate—migraine	0.000447	0.00197	CcSEcCtD
Bezafibrate—Insomnia—Topiramate—migraine	0.000444	0.00196	CcSEcCtD
Bezafibrate—Rash—Valproic Acid—migraine	0.000443	0.00196	CcSEcCtD
Bezafibrate—Dermatitis—Valproic Acid—migraine	0.000443	0.00196	CcSEcCtD
Bezafibrate—Pruritus—Timolol—migraine	0.000443	0.00196	CcSEcCtD
Bezafibrate—Headache—Valproic Acid—migraine	0.000441	0.00195	CcSEcCtD
Bezafibrate—PPARA—Transmembrane transport of small molecules—HTR3A—migraine	0.000437	0.00647	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—SCN1A—migraine	0.000433	0.00642	CbGpPWpGaD
Bezafibrate—Dyspepsia—Topiramate—migraine	0.000432	0.00191	CcSEcCtD
Bezafibrate—CYP1A1—central nervous system—migraine	0.000432	0.00966	CbGeAlD
Bezafibrate—Hypersensitivity—Gabapentin—migraine	0.00043	0.0019	CcSEcCtD
Bezafibrate—Diarrhoea—Timolol—migraine	0.000428	0.00189	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—HTR7—migraine	0.000424	0.00629	CbGpPWpGaD
Bezafibrate—Constipation—Topiramate—migraine	0.000419	0.00185	CcSEcCtD
Bezafibrate—Pain—Topiramate—migraine	0.000419	0.00185	CcSEcCtD
Bezafibrate—Nausea—Valproic Acid—migraine	0.000418	0.00184	CcSEcCtD
Bezafibrate—Dizziness—Timolol—migraine	0.000414	0.00183	CcSEcCtD
Bezafibrate—Pruritus—Gabapentin—migraine	0.000413	0.00182	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Topiramate—migraine	0.000401	0.00177	CcSEcCtD
Bezafibrate—Diarrhoea—Gabapentin—migraine	0.000399	0.00176	CcSEcCtD
Bezafibrate—Rash—Timolol—migraine	0.000395	0.00174	CcSEcCtD
Bezafibrate—Dermatitis—Timolol—migraine	0.000394	0.00174	CcSEcCtD
Bezafibrate—Headache—Timolol—migraine	0.000392	0.00173	CcSEcCtD
Bezafibrate—Urticaria—Topiramate—migraine	0.00039	0.00172	CcSEcCtD
Bezafibrate—Abdominal pain—Topiramate—migraine	0.000388	0.00171	CcSEcCtD
Bezafibrate—Dizziness—Gabapentin—migraine	0.000386	0.0017	CcSEcCtD
Bezafibrate—CYP1A1—Oxidative Stress—FOS—migraine	0.000385	0.00571	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—TRPM8—migraine	0.000382	0.00566	CbGpPWpGaD
Bezafibrate—Nausea—Timolol—migraine	0.000372	0.00164	CcSEcCtD
Bezafibrate—CYP2C8—brain—migraine	0.000371	0.00831	CbGeAlD
Bezafibrate—PPARG—Developmental Biology—SCN2A—migraine	0.000368	0.00546	CbGpPWpGaD
Bezafibrate—Rash—Gabapentin—migraine	0.000368	0.00162	CcSEcCtD
Bezafibrate—Dermatitis—Gabapentin—migraine	0.000367	0.00162	CcSEcCtD
Bezafibrate—PPARD—Generic Transcription Pathway—NOTCH4—migraine	0.000367	0.00544	CbGpPWpGaD
Bezafibrate—Headache—Gabapentin—migraine	0.000365	0.00161	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—ESR1—migraine	0.000363	0.00537	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Topiramate—migraine	0.000361	0.0016	CcSEcCtD
Bezafibrate—PPARG—Circadian rythm related genes—NPS—migraine	0.000354	0.00525	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—SLC6A4—migraine	0.000347	0.00514	CbGpPWpGaD
Bezafibrate—Pruritus—Topiramate—migraine	0.000347	0.00153	CcSEcCtD
Bezafibrate—Nausea—Gabapentin—migraine	0.000346	0.00153	CcSEcCtD
Bezafibrate—CYP1A1—brain—migraine	0.000343	0.00767	CbGeAlD
Bezafibrate—PPARG—Developmental Biology—MEF2D—migraine	0.000337	0.00499	CbGpPWpGaD
Bezafibrate—Diarrhoea—Topiramate—migraine	0.000336	0.00148	CcSEcCtD
Bezafibrate—PPARD—Generic Transcription Pathway—PGR—migraine	0.000336	0.00497	CbGpPWpGaD
Bezafibrate—CYP3A4—nervous system—migraine	0.000329	0.00737	CbGeAlD
Bezafibrate—Dizziness—Topiramate—migraine	0.000324	0.00143	CcSEcCtD
Bezafibrate—CYP3A4—central nervous system—migraine	0.000317	0.00709	CbGeAlD
Bezafibrate—PPARD—Generic Transcription Pathway—NOTCH3—migraine	0.000312	0.00462	CbGpPWpGaD
Bezafibrate—Rash—Topiramate—migraine	0.000309	0.00137	CcSEcCtD
Bezafibrate—Dermatitis—Topiramate—migraine	0.000309	0.00136	CcSEcCtD
Bezafibrate—Headache—Topiramate—migraine	0.000307	0.00136	CcSEcCtD
Bezafibrate—PPARG—Circadian rythm related genes—HTR7—migraine	0.000304	0.00451	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—migraine	0.000304	0.0045	CbGpPWpGaD
Bezafibrate—Nausea—Topiramate—migraine	0.000291	0.00129	CcSEcCtD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ATP1A3—migraine	0.00029	0.00429	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ATP1A2—migraine	0.00029	0.00429	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—NOTCH4—migraine	0.00028	0.00414	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—migraine	0.000279	0.00413	CbGpPWpGaD
Bezafibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—migraine	0.000275	0.00408	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—PGR—migraine	0.000256	0.00379	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—HTR3A—migraine	0.000246	0.00365	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—TNF—migraine	0.000238	0.00352	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—NOTCH3—migraine	0.000238	0.00352	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CACNA1A—migraine	0.000228	0.00338	CbGpPWpGaD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—TNF—migraine	0.000213	0.00316	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—NOTCH4—migraine	0.0002	0.00297	CbGpPWpGaD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—migraine	0.000197	0.00292	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CACNA1A—migraine	0.00019	0.00282	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—PGR—migraine	0.000183	0.00271	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—TNF—migraine	0.000181	0.00268	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—ESR1—migraine	0.000179	0.00265	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—NOTCH4—migraine	0.000177	0.00262	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CACNA1A—migraine	0.000174	0.00258	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—NOTCH3—migraine	0.00017	0.00252	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PGR—migraine	0.000162	0.00239	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—NOTCH3—migraine	0.00015	0.00223	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—TNF—migraine	0.000147	0.00218	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	0.000147	0.00218	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—ESR1—migraine	0.000137	0.00202	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—NOTCH4—migraine	0.000135	0.00199	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—TNF—migraine	0.00013	0.00192	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CACNA1A—migraine	0.000125	0.00185	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PGR—migraine	0.000123	0.00182	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—NOTCH3—migraine	0.000114	0.0017	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CACNA1A—migraine	9.81e-05	0.00145	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—ESR1—migraine	9.78e-05	0.00145	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH4—migraine	9.65e-05	0.00143	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PGR—migraine	8.82e-05	0.00131	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ESR1—migraine	8.63e-05	0.00128	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—NOTCH3—migraine	8.2e-05	0.00122	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—MTHFR—migraine	7.55e-05	0.00112	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—ESR1—migraine	6.57e-05	0.000974	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—MTHFR—migraine	6.29e-05	0.000931	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TNF—migraine	6.23e-05	0.000922	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CACNA1A—migraine	6.15e-05	0.000911	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—MTHFR—migraine	5.75e-05	0.000852	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CACNA1A—migraine	5.64e-05	0.000835	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR1—migraine	4.71e-05	0.000698	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—migraine	4.46e-05	0.000661	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—migraine	4.12e-05	0.000611	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—migraine	3.25e-05	0.000481	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CACNA1A—migraine	3.03e-05	0.000448	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—migraine	2.03e-05	0.000301	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—migraine	1.86e-05	0.000276	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—migraine	1e-05	0.000148	CbGpPWpGaD
